SYNTHON HISPANIA SL
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SYNTHON HISPANIA SL
Live alerts from global media, monitored by Business Radar
2023-11-14 (pharmabiz.net)
Synthon launched Osiren in Costa Salguero
Synthon-Bagó held an event to launch its new product Osiren MS. This is their brand indicated for multiple sclerosis and based on ozanimod. The main neurologists were summoned to the meeting held last Thursday in Costa Salguero.
Read more